A new stent for heart disease
Part of Heart & circulation clinical trials.
This trial tests a new type of stent (a small mesh tube) for people with heart disease who need a procedure to open blocked arteries. It aims to see if the stent is safe and works well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old
- Have a type of heart disease (like stable angina or a recent heart attack) that can be treated with a stent
- Be a candidate for bypass surgery (even though you're getting a stent)
- Be able to take blood thinners (aspirin plus another one) for at least a year after the procedure
- Women: not be pregnant or planning pregnancy for 12 months; not breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who need a coronary (heart) stent to see how they do after treatment. It does not sound like an experimental drug trial for you—it’s mainly about collecting health information after a stent procedure.
This trial tests a new heart stent called MiStent II to treat narrowed coronary (heart) arteries. It looks at whether the stent is safe and works well for people who need a procedure to restore blood flow.
This trial tests a new stent system for treating narrowed heart arteries. If you have coronary artery disease with one or two blockages that are at least 70% narrowed, this procedure might be an option for you.
This trial tests whether implanting stents in non-obstructive, high-risk plaques (thin-capped fatty plaques) can prevent future heart attacks. It is for people who have already had treatment for a recent heart attack or unstable angina and have additional plaques that are not severely blocking blood flow but are vulnerable.
This trial tests a new type of stent made from magnesium that slowly dissolves over time. It is for people who have a long blockage in a heart artery that has not been treated before and may be a good option for those who are stable and have not had a recent heart attack.
This Phase 4 study tests a way to measure blood flow in heart arteries to help doctors choose the best stent plan. It may help improve safety and effectiveness for people having elective heart stent procedures for stable angina or certain heart attacks.
Hear when a new Ischemic Heart Disease (IHD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.